139 results on '"Olaizola, Paula"'
Search Results
2. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
3. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma
4. OS-105-YI Collagen-integrin signaling re-establishes bile duct morphogenesis and promotes adult ductular regeneration
5. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
6. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
7. Seroprevalence of Toxoplasma gondii and Neospora caninum in family farming goats from the Luracatao Valley, Salta, Argentina
8. Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
9. A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
10. Wnt–β-catenin signalling in liver development, health and disease
11. Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
12. Novel platinum-based chemotherapeutic agents halt cholangiocarcinoma progression through the induction of inter-strand DNA breaks, preventing DNA repair mechanisms
13. Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
14. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
15. Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
16. KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
17. Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
18. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
19. 178 - THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER- SUMOYLATION IN CHOLANGIOCARCINOMA
20. 159 - KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
21. 177 - NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS HALT CHOLANGIOCARCINOMA PROGRESSION THROUGH THE INDUCTION OF INTERSTRAND DNA BREAKS, PREVENTING DNA REPAIR MECHANISMS
22. LIQUID BIOPSY PROTEINS AS PSC-SPECIFIC AND PAN-CCA BIOMARKERS OF CANCER RISK, EARLY DIAGNOSIS AND SURVIVAL MIRRORING TUMOR CELLS
23. Aberrant fucosylation sustains the NOTCH and EGFR/NF-kB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma
24. PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
25. The uptake of extracellular lipids promotes cholangiocarcinoma progression
26. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
27. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis
28. SAT-159-YI Mitochondrial integrity and auto (mito)phagy are disrupted in experimental models of primary biliary cholangitis, contributing to disease pathogenesis
29. Proceso de toma de decisiones en la transición al cuidado hospice. Hospitalidad compasiva en el final de la vida
30. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
31. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
32. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
33. Primary cilia loss promotes reactivation of morphogenesis and cyst-fission through a deregulated TGFβ-ECM-Integrin axis in polycystic liver disease
34. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
35. FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
36. Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
37. Unscrambling a novel pathogenic role for interleukin-20 in acute hepatitis and bacterial infection: A double-edged sword?
38. FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
39. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
40. Targeting UBC9-Mediated Protein Hyper-SUMOylation in Cystic Cholangiocytes Halts Polycystic Liver Disease in Experimental Models
41. SAT-244 - Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
42. SAT-238 - Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
43. SAT-223 - Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
44. SAT-226 - KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
45. SAT-212 - Novel platinum-based chemotherapeutic agents halt cholangiocarcinoma progression through the induction of inter-strand DNA breaks, preventing DNA repair mechanisms
46. OS-074-YI - A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
47. Lignins from Agroindustrial by-Products as Natural Ingredients for Cosmetics: Chemical Structure and In Vitro Sunscreen and Cytotoxic Activities
48. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
49. Pathogenesis of Cholangiocarcinoma
50. Lignins from Agroindustrial by-Products as Natural Ingredients for Cosmetics: Chemical Structure and In Vitro Sunscreen and Cytotoxic Activities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.